We are live on
!
Find out more
TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
1-Year Est. Return
39.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$13.2M
(+3.1%)
Cap. Flow
-$5.92M
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
21.02%
Holding
110
New
19
Increased
34
Reduced
34
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$6.63M |
| 2 |
AYX
Alteryx Inc
AYX
|
+$6M |
| 3 |
ACI Worldwide
ACIW
|
+$5.54M |
| 4 |
ENV
ENVESTNET, INC.
ENV
|
+$5.4M |
| 5 |
Silicon Motion
SIMO
|
+$5.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$11.1M |
| 2 |
Take-Two Interactive
TTWO
|
+$7.54M |
| 3 |
RP
RealPage, Inc.
RP
|
+$6.76M |
| 4 |
Tower Semiconductor
TSEM
|
+$6.15M |
| 5 |
AIRM
Air Methods Corp
AIRM
|
+$5.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Industrials | 25.41% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Healthcare | 11.08% |
| 5 | Financials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Western Alliance Bancorporation
WAL
$8.84B
| $6.15M | 1.39% |
124,961
+8,050
| +7% | +$383K |
|
27
AMERISAFE
AMSF
$641M
| $6.08M | 1.38% |
106,713
+26,195
| +33% | +$1.49M |
|
|
ENV
28
DELISTED
ENVESTNET, INC.
ENV
| $5.95M | 1.35% |
+150,301
| New | +$5.4M |
|
|
COHR
29
DELISTED
Coherent Inc
COHR
| $5.88M | 1.33% |
26,143
+2,396
| +10% | +$550K |
|
|
TACO
30
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $5.85M | 1.33% |
425,780
+34,517
| +9% | +$457K |
|
31
Littelfuse
LFUS
$10.2B
| $5.82M | 1.32% |
35,292
+1,945
| +6% | +$312K |
|
32
Bank OZK
OZK
$5.61B
| $5.72M | 1.3% |
121,996
+8,943
| +8% | +$425K |
|
|
DATA
33
DELISTED
Tableau Software, Inc.
DATA
| $5.61M | 1.27% |
91,604
+16,278
| +22% | +$955K |
|
|
34
ACI Worldwide
ACIW
$5.78B
| $5.53M | 1.25% |
+247,323
| New | +$5.54M |
|
35
Booz Allen Hamilton
BAH
$7.74B
| $5.34M | 1.21% |
164,133
-22,875
| -12% | -$823K |
|
36
Fabrinet
FN
$17.7B
| $5.32M | 1.21% |
124,693
-9,082
| -7% | -$342K |
|
|
CONE
37
DELISTED
CyrusOne Inc Common Stock
CONE
| $5.17M | 1.17% |
92,807
+52,807
| +132% | +$2.92M |
|
38
Charles River Laboratories
CRL
$10.6B
| $5.12M | 1.16% |
50,567
-11,220
| -18% | -$1.03M |
|
|
39
Silicon Motion
SIMO
$8.57B
| $5.1M | 1.16% |
+105,756
| New | +$5.23M |
|
|
PRAH
40
DELISTED
PRA Health Sciences, Inc.
PRAH
| $5.05M | 1.14% |
67,305
-16,950
| -20% | -$1.18M |
|
41
Casella Waste Systems
CWST
$5.95B
| $5.04M | 1.14% |
307,080
-5,048
| -2% | -$74.6K |
|
|
LEXEA
42
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $5.03M | 1.14% |
+93,163
| New | +$4.7M |
|
43
Coherent
COHR
$55.8B
| $4.83M | 1.09% |
+140,730
| New | +$4.56M |
|
44
Cavco Industries
CVCO
$4.37B
| $4.74M | 1.07% |
36,546
-16,367
| -31% | -$1.95M |
|
45
PRA Group
PRAA
$663M
| $4.72M | 1.07% |
124,475
+35,568
| +40% | +$1.24M |
|
|
IDTI
46
DELISTED
Integrated Device Technology I
IDTI
| $4.7M | 1.06% |
182,077
+146,319
| +409% | +$3.56M |
|
|
WNS
47
DELISTED
WNS Holdings
WNS
| $4.67M | 1.06% |
135,970
+76,517
| +129% | +$2.44M |
|
48
Icon
ICLR
$12.8B
| $4.67M | 1.06% |
47,766
+9,287
| +24% | +$821K |
|
49
Bio-Techne
TECH
$11.2B
| $4.65M | 1.05% |
+158,300
| New | +$4.33M |
|
50
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $4.63M | 1.05% |
59,962
-1,545
| -3% | -$110K |
|
Similar funds
IVP
FMBTD
EHPM
VMV
SIM
HAM
VIMU
AC
Tygh Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Tygh Capital Management held 110 positions worth $441M, up 3.1% from $428M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Tygh Capital Management's Q2 2017 filing shows 19 new, 34 increased, 34 reduced and 23 closed positions. Its largest new stake was Ligand Pharmaceuticals: 94,825 shares worth $7.18M. The largest sale was Veeva Systems, an estimated $11.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Tygh Capital Management's largest Q2 2017 buy was Ligand Pharmaceuticals: 94,825 shares worth $7.18M.
- Tygh Capital Management added most to Alteryx Inc in Q2 2017, an estimated $6M increase.
- Tygh Capital Management's biggest Q2 2017 reduction was Take-Two Interactive, cutting an estimated $7.54M.
- Tygh Capital Management fully exited Veeva Systems in Q2 2017, selling an estimated $11.1M.
- Tygh Capital Management's ten largest holdings make up 21% of its $441M portfolio in Q2 2017.
- Tygh Capital Management opened 19 new positions and closed 23 in Q2 2017.
- Tygh Capital Management's portfolio value rose 3.1% quarter-over-quarter to $441M.
Based on Tygh Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.